Canadian government ordered to release unpublished Tamiflu data in landmark ruling
BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3112 (Published 13 July 2018) Cite this as: BMJ 2018;362:k3112Opinion
Canadian court orders release of unpublished clinical trial data
- Gareth Iacobucci
- The BMJ
The Canadian government has been instructed to release unpublished clinical trial data relating to Tamiflu, Relenza, and three human papillomavirus vaccines immediately, in a landmark ruling hailed as a “major victory” for transparency.
The case was brought by Peter Doshi, assistant professor at the University of Maryland and associate editor of The BMJ, after Health Canada refused his request to obtain unpublished information relating to Tamiflu, Relenza, Gardasil, Gardasil 9, and Cervarix because he would not sign a confidentiality agreement that would have prevented him from disseminating or publishing anything on it.
A federal court judge said it was “unreasonable” for Health Canada to impose a confidentiality requirement as a condition for the disclosure …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.